Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brett Carver

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
The Journal of Urology|September 6, 2023
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the RetroperitoneumRichard S Matulewicz, Nicole Benfante, Samuel A Funt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancerMichael J Zelefsky, Marisa Kollmeier, Brett Cox, et al.
Clinical Genitourinary Cancer|September 22, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node DissectionFady Baky, Nicole Liso, Brandon Williams, et al.
Plos One|April 18, 2012
Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screeningKimberly Brown Dahlman, Joel S Parker, Tambudzai Shamu, et al.
Plant Physiology|February 12, 2021
A semi-dominant NLR allele causes whole-seedling necrosis in wheatHaiyan Jia, Shulin Xue, Lei Lei, et al.
Genes & Development|August 19, 2008
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic eventsCaterina Nardella, Zhenbang Chen, Leonardo Salmena, et al.
Urology|March 8, 2011
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an updateAmit Gupta, Andrew H Feifer, Geoffrey T Gotto, et al.
Cancer|July 17, 2015
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implicationsDana E Rathkopf, Steven M Larson, Aseem Anand, et al.
European Urology|October 29, 2024
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended DissectionKarim A Touijer, Emily A Vertosick, Daniel D Sjoberg, et al.
Elife|September 5, 2018
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and deathHaley Hieronymus, Rajmohan Murali, Amy Tin, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
The Journal of Urology|September 6, 2023
Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the RetroperitoneumRichard S Matulewicz, Nicole Benfante, Samuel A Funt, et al.
International Journal of Radiation Oncology, Biology, Physics|February 15, 2012
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancerMichael J Zelefsky, Marisa Kollmeier, Brett Cox, et al.
Clinical Genitourinary Cancer|September 22, 2024
Long-term Clinical Outcomes of Patients With Negative Pathology (pN0) at Primary Retroperitoneal Lymph Node DissectionFady Baky, Nicole Liso, Brandon Williams, et al.
Plos One|April 18, 2012
Modulators of prostate cancer cell proliferation and viability identified by short-hairpin RNA library screeningKimberly Brown Dahlman, Joel S Parker, Tambudzai Shamu, et al.
Plant Physiology|February 12, 2021
A semi-dominant NLR allele causes whole-seedling necrosis in wheatHaiyan Jia, Shulin Xue, Lei Lei, et al.
Genes & Development|August 19, 2008
Aberrant Rheb-mediated mTORC1 activation and Pten haploinsufficiency are cooperative oncogenic eventsCaterina Nardella, Zhenbang Chen, Leonardo Salmena, et al.
Urology|March 8, 2011
Outcomes after resection of postchemotherapy residual neck mass in patients with germ cell tumors--an updateAmit Gupta, Andrew H Feifer, Geoffrey T Gotto, et al.
Cancer|July 17, 2015
Everolimus combined with gefitinib in patients with metastatic castration-resistant prostate cancer: Phase 1/2 results and signaling pathway implicationsDana E Rathkopf, Steven M Larson, Aseem Anand, et al.
European Urology|October 29, 2024
Pelvic Lymph Node Dissection in Prostate Cancer: Update from a Randomized Clinical Trial of Limited Versus Extended DissectionKarim A Touijer, Emily A Vertosick, Daniel D Sjoberg, et al.
Elife|September 5, 2018
Tumor copy number alteration burden is a pan-cancer prognostic factor associated with recurrence and deathHaley Hieronymus, Rajmohan Murali, Amy Tin, et al.
Pageof 4